{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:04:23Z","timestamp":1787976263546,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["C26A14CPRB, C26A158NJR, RM116154EC670667 RP11715C7D08BDC2, and RM11715C7D01147A"],"award-info":[{"award-number":["C26A14CPRB, C26A158NJR, RM116154EC670667 RP11715C7D08BDC2, and RM11715C7D01147A"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Internazionale D'AMATO Onlus"},{"name":"Fondazione Frisiani-Santini"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5265-5","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:15:11Z","timestamp":1547108111000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review"],"prefix":"10.1186","volume":"19","author":[{"given":"Monica","family":"Piedimonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Ottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariadomenica","family":"Divona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mirabilii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Licchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cicconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pelliccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapaola","family":"Leporace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lo Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"4","key":"5265_CR1","first-page":"362","volume":"47","author":"BZ Carter","year":"2010","unstructured":"Carter BZ, Mak DH, Cortes J, Andreeff M. The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it? SeminHematol. 2010;47(4):362\u201370.","journal-title":"SeminHematol"},{"issue":"6","key":"5265_CR2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood.V88.6.2236.bloodjournal8862236","volume":"88","author":"A Hochhaus","year":"1996","unstructured":"Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood. 1996;88(6):2236\u201340.","journal-title":"Blood"},{"issue":"7","key":"5265_CR3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"JV Melo","year":"1996","unstructured":"Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88(7):2375\u201384.","journal-title":"Blood"},{"issue":"3","key":"5265_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1365-2141.2000.02042.x","volume":"109","author":"S Branford","year":"2000","unstructured":"Branford S, Rudzki Z, Hughes TP. A novel BCR\u00b1ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia. Br J Haematol. 2000;109(3):635\u20137.","journal-title":"Br J Haematol"},{"issue":"11","key":"5265_CR5","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/blood.V97.11.3668","volume":"97","author":"P Moreno Mdel","year":"2001","unstructured":"Moreno Mdel P, Cortinas MN, Bonomi R, Cardeza A. UriarteMdelR. A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypicalchronicmyeloproliferativesyndrome. Blood. 2001;97(11):3668\u20139.","journal-title":"Blood"},{"key":"5265_CR6","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/sj.leu.2403079","volume":"17","author":"B Schultheis","year":"2003","unstructured":"Schultheis B, Wang L, Clark RE, Melo JV. BCR-ABL with an e6a2 fusion in aCML patient diagnosed in blast crisis. Leukemia. 2003;17:2054\u20135.","journal-title":"Leukemia"},{"key":"5265_CR7","doi-asserted-by":"crossref","unstructured":"Montillo M, Tedeschi A, Pagano L, Venditti A, Ferrara F, Fabris P, Martino B, Musso M, De Rosa G, Specchia G, Monaco M, Sparaventi G, Spadea A, Palmas A, Deplano W, Manna A, Melillo L, Miraglia E, Mirto S, Mandelli F. Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. Br J Haematol 2000;111(1):334\u2013337.","DOI":"10.1046\/j.1365-2141.2000.02277.x"},{"issue":"12","key":"5265_CR8","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cav\u00e9 H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, Gonz\u00e1lez M, Viehmann S, Malec M, Saglio G, van Dongen JJ. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe against Cancer program. Leukemia. 2003;17(12):2318\u201357.","journal-title":"Leukemia"},{"issue":"12","key":"5265_CR9","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","volume":"99","author":"C Thiede","year":"2002","unstructured":"Thiede C, Steudel C, Mohr B, Schaich M, Sch\u00e4kel U, Platzbecker U, Wermke M, Bornh\u00e4user M, Ritter M, Neubauer A, Ehninger G, Illmer T. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99(12):4326\u201335.","journal-title":"Blood"},{"issue":"20","key":"5265_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield D, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood"},{"issue":"4","key":"5265_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, L\u00f6wenberg B, Bloomfield CD. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"4","key":"5265_CR12","first-page":"642","volume":"127","author":"CP Soupir","year":"2007","unstructured":"Soupir CP, Vergilio JA, Dal Cin P, Muzikansky A, Kantarjian H, Jones D, Hasserjian RP. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J ClinPathol. 2007;127(4):642\u201350.","journal-title":"Am J ClinPathol"},{"issue":"1","key":"5265_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ajh.24928","volume":"93","author":"VL Lazarevic","year":"2018","unstructured":"Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A. Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: a survey from the acute leukemia working party of the European society for blood and marrow transplantation (EBMT). Am J Hematol. 2018;93(1):31\u20139.","journal-title":"Am J Hematol"},{"issue":"3","key":"5265_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00428-015-1802-z","volume":"467","author":"A Zagaria","year":"2015","unstructured":"Zagaria A, Anelli L, Coccaro N, Tota G, Casieri P, Cellamare A, Impera L, Brunetti C, Minervini A, Minervini CF, Delia M, Cumbo C, Orsini P, Specchia G, Albano F. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Virchows Arch. 2015;467(3):357\u201363.","journal-title":"Virchows Arch"},{"issue":"8","key":"5265_CR15","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1016\/j.leukres.2010.02.022","volume":"34","author":"SE Langabeer","year":"2010","unstructured":"Langabeer SE, Crampe M, Kelly J, Fadalla K, Connaghan G, Conneally E. Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts. Leuk Res. 2010;34(8):e204\u20135.","journal-title":"Leuk Res"},{"key":"5265_CR16","first-page":"1139","volume":"90","author":"G Roti","year":"2005","unstructured":"Roti G, La Starza R, Gorello P, Gottardi E, Crescenzi B, Martelli MF. Mecucci C. e6a2 BCR\/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia. Haematologica. 2005;90:1139\u201341.","journal-title":"Haematologica"},{"key":"5265_CR17","first-page":"11","volume":"122","author":"HK Vefring","year":"2009","unstructured":"Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases. ActaHaematol. 2009;122:11\u20136.","journal-title":"ActaHaematol"},{"key":"5265_CR18","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00277-011-1169-4","volume":"90","author":"KA Beel","year":"2011","unstructured":"Beel KA, Lemmens J, Vranckx H, Maertens J, Vandenberghe P. CML with e6a2 BCR-ABL1 transcript: an aggressive entity? Ann Hematol. 2011;90:1241\u20133.","journal-title":"Ann Hematol"},{"key":"5265_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5507\/bp.2011.030","volume":"155","author":"DM RohonP","year":"2011","unstructured":"RohonP DM, Calabkova L, Mojzikova R, Katrincsakova B, Rusinakova Z, Lapcikova A, Raida L, Faber E, Jarosova M, Divoky V, Indrak K. Identification of e6a2 BCR-ABL fusion in a Philadelphia positive CML with marked basophilia: implications for treatment strategy. Biomed Pap Med FacUnivPalacky Olomouc Czech Repub. 2011;155:187\u201390.","journal-title":"Biomed Pap Med FacUnivPalacky Olomouc Czech Repub"},{"key":"5265_CR20","first-page":"9071702","volume":"2017","author":"M Crampe","year":"2017","unstructured":"Crampe M, Haslam K, Groarke E, Kelleher E, O'Shea D, Conneally E, Langabeer SE. Chronic myeloid leukemia with an e6a2 BCR-ABL1 fusion transcript: cooperating mutations at blast crisis and molecular monitoring. Case Rep Hematol. 2017;2017:9071702.","journal-title":"Case Rep Hematol"},{"issue":"50","key":"5265_CR21","doi-asserted-by":"publisher","first-page":"e9160","DOI":"10.1097\/MD.0000000000009160","volume":"96","author":"Y Harada","year":"2017","unstructured":"Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I. Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: a case report and literature review. Medicine (Baltimore). 2017;96(50):e9160.","journal-title":"Medicine (Baltimore)"},{"key":"5265_CR22","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1182\/blood-2007-08-107508","volume":"111","author":"DS Ritchie","year":"2008","unstructured":"Ritchie DS, McBean M, Westerman DA, Kovalenko S, Seymour JF, Dobrovic A. Complete molecular response of e6a2 BCRABL-positive acute myeloid leukemia toimatinib then dasatinib. Blood. 2008;111:2896\u20138.","journal-title":"Blood"},{"key":"5265_CR23","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/sj.leu.2404792","volume":"21","author":"S Corm","year":"2007","unstructured":"Corm S, Renneville A, Rad-Quesnel E, Grardel N, Preudhomme C, Quesnel B. Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2 BCR\/ABL: use of dasatinib and reduced-conditioning stem-cell transplantation. Leukemia. 2007;21:2376\u20137.","journal-title":"Leukemia"},{"issue":"1","key":"5265_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/10428194.2012.701739","volume":"54","author":"S Konoplev","year":"2013","unstructured":"Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma. 2013;54(1):138\u201344.","journal-title":"Leuk Lymphoma"},{"key":"5265_CR25","first-page":"17","volume":"7","author":"J Yao","year":"2017","unstructured":"Yao J, Douer D, Wang L, Arcila ME, Nafa K, Chiu A. A case of acute myeloid leukemia with e6a2 BCR-ABL fusion transcript acquired after progressing from chronic myelomonocytic leukemia. Leuk Res Rep. 2017;7:17\u20139.","journal-title":"Leuk Res Rep"},{"key":"5265_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/10428190500138138","volume":"46","author":"C Popovici","year":"2005","unstructured":"Popovici C, Cailleres S, David M, Lafage-Pochitaloff M, Sainty D, Mozziconacci MJ. E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to imatinib. Leuk Lymphoma. 2005;46:1375\u20137.","journal-title":"Leuk Lymphoma"},{"issue":"44","key":"5265_CR27","doi-asserted-by":"publisher","first-page":"e12949","DOI":"10.1097\/MD.0000000000012949","volume":"97","author":"X Shao","year":"2018","unstructured":"Shao X, Chen D, Xu P, Peng M, Guan C, Xie P, Yuan C, Chen B. Primary Philadelphia chromosome positive acute myeloid leukemia: A case report. Medicine (Baltimore). 2018 Nov;97(44):e12949.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"5265_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.leukres.2014.11.027","volume":"39","author":"HP Erba","year":"2015","unstructured":"Erba HP. Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy. Leuk Res. 2015;Feb;39(2):183\u201391.","journal-title":"Leuk Res"},{"issue":"8","key":"5265_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood-2013-06-511154","volume":"123","author":"SA Rushworth","year":"2014","unstructured":"Rushworth SA, Murray MY, Zaitseva L, Bowles KM, MacEwan DJ. Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia. Blood. 2014;123(8):1229\u201338.","journal-title":"Blood"},{"key":"5265_CR30","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/sj.leu.2401916","volume":"14","author":"M Dupont","year":"2000","unstructured":"Dupont M, Jourdan E, Chiesa J. Identification of E6A2 BCR-ABL fusion in a Philadelphia-positive CML. Leukemia. 2000;14:2011\u20132.","journal-title":"Leukemia"},{"key":"5265_CR31","first-page":"611","volume":"89","author":"S Colla","year":"2004","unstructured":"Colla S, Sammarelli G, Voltolini S, Crugnola M, Sebastio P. Giuliani N. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease? Haematologica. 2004;89:611\u20133.","journal-title":"Haematologica"},{"key":"5265_CR32","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/sj.leu.2403476","volume":"18","author":"S Hayette","year":"2004","unstructured":"Hayette S, Tigaud I, Thomas X, French M, Perrin MC, Nicolini F, Michallet M, Magaud JP. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report. Leukemia. 2004;18:1735\u20136.","journal-title":"Leukemia"},{"key":"5265_CR33","first-page":"216","volume":"116","author":"MJ Gr\u00e9goire","year":"2006","unstructured":"Gr\u00e9goire MJ, Latger-Cannard V, Staal A, Bologna S, Leotard B, Rault JP, B\u00e9ry-Dexheimer M, Jonveaux P. Identification of an acute basophilic leukaemia carrying a rare e6a2 BCR-ABL transcript. ActaHaematol. 2006;116:216\u20138.","journal-title":"ActaHaematol"},{"key":"5265_CR34","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3324\/haematol.11737","volume":"92","author":"T Burmeister","year":"2007","unstructured":"Burmeister T, Schwartz S, Taubald A, Jost E, Lipp T, Schneller F, Diedrich H, Thomssen H, Mey UJ, Eucker J, Rieder H, G\u00f6kbuget N, Hoelzer D, Thiel E. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica. 2007;92:1699\u2013702.","journal-title":"Haematologica"},{"key":"5265_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.leukres.2007.05.022","volume":"32","author":"M Breccia","year":"2008","unstructured":"Breccia M, Cannella L, Diverio D, Streponi P, Nanni M, Stefanizzi C, Natalino F, Mecarocci S, Alimena G. Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR\/ABL fusion transcript, JAK2 negativity and complete response to imatinib. Leuk Res. 2008;32:177\u201380.","journal-title":"Leuk Res"},{"key":"5265_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/sj.leu.2404949","volume":"22","author":"S Schnittger","year":"2008","unstructured":"Schnittger S, Bacher U, Kern W, Haferlach T, Hertenstein B, Haferlach C. A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinibmesylate, which were replaced by T315I after subsequent dasatinib treatment. Leukemia. 2008;22:856\u20138.","journal-title":"Leukemia"},{"key":"5265_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/10428190701216402","volume":"48","author":"F Torres","year":"2007","unstructured":"Torres F, Ivanova-Dragoeva A, Pereira M, Veiga J, Rodrigues AS, Sousa AB, Tavares P, Fernandes AR. An e6a2 BCR-ABL fusion transcript in a CML patient having an iliac chloroma at initial presentation. Leuk Lymphoma. 2007;48:1034\u20137.","journal-title":"Leuk Lymphoma"},{"key":"5265_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40364-018-0147-6","volume":"6","author":"MK Bratt\u00e5s","year":"2018","unstructured":"Bratt\u00e5s MK, Lilleeng K, Hovland R, L\u00e6greid IJ, Vorland M, Leh F, Bruserud \u00d8, Gjertsen BT, Reikvam H. Philadelphia chromosome positive AML arising from JAK2- positive myelofibrosis. Biomark Res. 2018;6:33.","journal-title":"Biomark Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5265-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5265-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5265-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T19:11:22Z","timestamp":1578597082000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5265-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5265"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5265-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and the accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}